Tucson, Ariz. (January 26, 2022) – 2022 Tournament Chairman Josh Robinson announced today a number of the early player commitments for the 2022 Cologuard Classic, set to be played February 25 – 27 at Omni Tucson National Resort’s Catalina Course. PGA TOUR Champions’ golfers set to compete in this year's tournament include: 2021 Charles Schwab Cup winner and 2020 Cologuard Classic tournament champion Bernhard Langer; University of Arizona alum and reigning PGA TOUR Champions Rookie of the Year Jim Furyk; World Golf Hall of Fame member Ernie Els; Cologuard ambassador Jerry Kelly; defending tournament champion Kevin Sutherland; and Miguel Angel Jimenez, winner of this past weekend’s Mitsubishi Electric Championship in Hawaii.
The 2022 Cologuard Classic will feature a 78-player field competing for a $1.7 million purse with $255,000 and 255 Charles Schwab Cup points going to the winner. PGA TOUR Champions golfers have until Friday, February 18 to commit to play in the Cologuard Classic. Therefore, the field will continue to change as players with higher priority rankings commit to play in the tournament.
Alpha Field List 2022 Cologuard Classic As of 1/26/2022
Jimenez, Miguel Angel
Olazabal, Jose Maria
Short, Jr., Wes
“The early commitments for this year’s tournament are really impressive,” said Robinson. “There’s definitely a buzz in the air about the event as ticket and hospitality package sales are strong. We have added a few new features this year including a Tailgate Zone, which is included with any grounds ticket and a party-deck with viewing options of both the 15th green and the 16th tee.”
Cologuard Classic tickets and hospitality packages are now on sale on the tournament’s website, www.CologuardClassic.com for Friday, Saturday and Sunday (Feb. 25 -27). Admission to the second round of the tournament on Saturday, Feb. 26th, includes admission to the golf tournament and the evening Cologuard Classic Military Tribute Concert sponsored by NOVA Home Loans & DM50 featuring country music artists Jake Owen and Diamond Rio.
Robinson also announced that the tournament will be closed to the public Monday through Thursday; open only to participants playing in the Caboose Cup Am-Am golf outing, the Tom Murphy Memorial Special Olympics Golf Tournament, The First Tee Tucson Youth Clinic or the Maestro Dobel Tequila Pro-Ams.
For more information on the 2022 Cologuard Classic, visit www.CologuardClassic.com or call 520-571-0400.
About The Tucson Conquistadores
The Tucson Conquistadores are the tournament management team that oversees the operations and the sales arm of the PGA TOUR Champions’ Cologuard Classic. Since their inception in 1962, the Conquistadores have contributed more than $36.5 million to local and national charities. The Conquistadores are comprised of up to 57 active business and professional members and a total membership of 224 who represent a cross-section of the Tucson community. In addition to their involvement with professional golf, the group has established the Tucson Conquistadores Foundation. Key beneficiaries of the Conquistadores' fundraising efforts include southern Arizona youth athletic programs, First Tee Tucson and colon cancer advocacy organizations. Follow the Tucson Conquistadores online at www.tucsonconquistadores.com and www.Facebook.com/TucsonConquistadores
About PGA TOUR Champions
PGA TOUR Champions is a membership organization of professional golfers age 50 and older, including 34 members of the World Golf Hall of Fame. The Tour’s mission is to provide financial opportunities for its players, entertain and inspire its fans, deliver substantial value to its partners, create outlets for volunteers to give back and generate significant charitable and economic impact in tournament communities. Follow PGA TOUR Champions online at PGATOUR.com, at facebook.com/PGATOURChampions, on Twitter @ChampionsTour and on Instagram @pgatourchampions.
All events are televised in the United States, with most receiving complete coverage on Golf Channel, the exclusive cable-television partner of PGA TOUR Champions. Tournament programming is available via 25+
TV linear partners in 145+ countries and territories, with 25 channels carrying long-form and/or highlights coverage, and 200+ hours of live coverage distributed in 135+ countries and territories. Programming is also available via the OTT platform GOLFTV powered by PGA TOUR in every market outside of the United States, excluding China and Korea, with live coverage distributed in 130+ countries and territories.
Cologuard was approved by the FDA in August 2014, and results from Exact Sciences' prospective 90-site, point-in-time, 10,000-patient pivotal trial in adults 50 years of age or older were published in the New England Journal of Medicine in March 2014. Cologuard is included in the American Cancer Society's (2018) colorectal cancer screening guidelines and the recommendations of the U.S. Preventive Services Task Force (2016, 2021) and National Comprehensive Cancer Network (2016). Cologuard is indicated to screen adults 45 years of age and older who are at average risk for colorectal cancer by detecting certain DNA markers and blood in the stool. Do not use Cologuard if you have had adenomas, have inflammatory bowel disease and certain hereditary syndromes, or have a personal or family history of colorectal cancer. Cologuard is not a replacement for colonoscopy in high-risk patients. Cologuard performance in adults ages 45-49 is estimated based on a large clinical study of patients 50 and older. Cologuard performance in repeat testing has not been evaluated.
The Cologuard test result should be interpreted with caution. A positive test result does not confirm the presence of cancer. Patients with a positive test result should be referred for diagnostic colonoscopy. A negative test result does not confirm the absence of cancer. Patients with a negative test result should discuss with their doctor when they need to be tested again. False positives and false negative results can occur. In a clinical study, 13% of people without cancer received a positive result (false positive) and 8% of people with cancer received a negative result (false negative). Rx only.
Medicare and most major insurers cover Cologuard. For more information about Cologuard, visit www.cologuard.com.
Tournament Media Contact: